Spectral AI (MDAI) Net Cash Flow Growth (1y) (2022 - 2026)
Spectral AI (MDAI) Net Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 76.43% |
| 10 | Spectral AI | 52.08 Mn | 40.43 Mn | 2.03 Mn | -141.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -141.96% |
| Dec 31, 2025 | 231.62% |
| Sep 30, 2025 | 99.50% |
| Jun 30, 2025 | -8.81% |
| Mar 31, 2025 | 65.52% |
| Dec 31, 2024 | 157.47% |
| Sep 30, 2024 | -289.98% |
| Jun 30, 2024 | -52.63% |
| Mar 31, 2024 | 239.13% |
| Dec 31, 2023 | -101.02% |
| Sep 30, 2023 | -156.18% |
| Jun 30, 2023 | -794.77% |
| Mar 31, 2023 | -1,171.44% |
| Dec 31, 2022 | 265,918.08% |
| Sep 30, 2022 | -6,392.72% |
| Jun 30, 2022 | 68.11% |
| Mar 31, 2022 | -118.71% |